title: HDP-CDV as an alternative for treatment of human herpesvirus-6 infections.
authors.forename: Pascale
authors.initials: P
authors.lastname: Bonnafous
authors.forename: Sofie
authors.initials: S
authors.lastname: Bogaert
authors.forename: Angélique N
authors.initials: AN
authors.lastname: Godet
authors.forename: Henri
authors.initials: H
authors.lastname: Agut
mesh_terms: D000998:Antiviral Agents / Q000493:pharmacokinetics / Q000494:pharmacology / Q000627:therapeutic use*; D002460:Cell Line; D003596:Cytosine / Q000031:analogs & derivatives* / Q000493:pharmacokinetics / Q000494:pharmacology / Q000627:therapeutic use; D015654:Herpesvirus 6, Human / Q000187:drug effects*; D006801:Humans; D008826:Microbial Sensitivity Tests; D063065:Organophosphonates / Q000493:pharmacokinetics / Q000494:pharmacology / Q000627:therapeutic use*; D019349:Roseolovirus Infections / Q000188:drug therapy*
chemical_list: D000998:Antiviral Agents; D063065:Organophosphonates; C525733:brincidofovir; D003596:Cytosine